TG Therapeutics Inc logo

TG Therapeutics Inc

STU:NKB2 (USA)   Ordinary Shares
€ 16.07 (+3.53%) May 13
78.73
P/B:
16.72
Market Cap:
€ 2.49B ($ 2.69B)
Enterprise V:
€ 2.39B ($ 2.59B)
Volume:
740.00
Avg Vol (2M):
2.02K
Also Trade In:

TG Therapeutics Inc Valuation Measures